Cite
HARVARD Citation
Orditura, M. et al. (2018). Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs. Breast. pp. 165-171. [Online].